Fan Claire, Younis Adam, Bookhout Christine E, Crockett Seth D
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Department of Pathology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Curr Treat Options Gastroenterol. 2018 Mar;16(1):182-202. doi: 10.1007/s11938-018-0176-0.
The purpose of this review is to summarize the management of serrated colorectal polyps (SPs), with a particular focus on the most common premalignant SP, sessile serrated adenoma or polyp (SSA/P). These lesions present a challenge for endoscopists with respect to detection and resection, and are also susceptible to pathologic misdiagnosis.
Patients with SSA/Ps are at an increased risk of future colorectal neoplasia, including advanced polyps and cancer. Reasonable benchmarks for SP detection rates are 5-7% for SSA/Ps and 10-12% for proximal SPs. Certain endoscopic techniques such as chromoendoscopy, narrow band imaging, water immersion, and wide-angle viewing may improve SSA/P detection. Emerging endoscopic techniques such as underwater polypectomy, suction pseudopolyp technique, and piecemeal cold snare polypectomy are helpful tools for the endoscopist's armamentarium for removing SSA/Ps. Proper orientation of SSA/P specimens can improve the accuracy of pathology readings. Patients with confirmed SSA/Ps and proximal HPs should undergo surveillance at intervals similar to what is recommended for patients with conventional adenomas. Patients with SSA/Ps may also be able to lower their risk of future polyps by targeting modifiable risk factors including tobacco and alcohol use and high-fat diets. NSAIDs and aspirin appear to be protective agents. SPs and SSA/Ps in particular are important colorectal cancer precursors that merit special attention to ensure adequate detection, resection, and surveillance.
本综述旨在总结锯齿状结直肠息肉(SPs)的管理,特别关注最常见的癌前SP,即无蒂锯齿状腺瘤或息肉(SSA/P)。这些病变在内镜检查的检测和切除方面给内镜医师带来了挑战,并且也容易出现病理误诊。
患有SSA/P的患者未来发生结直肠肿瘤(包括进展期息肉和癌症)的风险增加。SSA/P的SP检测率的合理基准为5%-7%,近端SP为10%-12%。某些内镜技术,如色素内镜检查、窄带成像、水浸法和广角观察,可能会提高SSA/P的检测率。新兴的内镜技术,如水下息肉切除术、吸引假息肉技术和分次冷圈套息肉切除术,是内镜医师切除SSA/P的有用工具。SSA/P标本的正确定向可以提高病理读数的准确性。确诊为SSA/P和近端高危息肉(HPs)的患者应按照与传统腺瘤患者相同的间隔进行监测。患有SSA/P的患者也可以通过针对可改变的风险因素(包括吸烟、饮酒和高脂饮食)来降低未来患息肉的风险。非甾体抗炎药(NSAIDs)和阿司匹林似乎是保护剂。SPs,尤其是SSA/Ps,是重要的结直肠癌前体,值得特别关注,以确保进行充分的检测、切除和监测。